Cargando…

Management of Women With an Unexpected Low Ovarian Response to Gonadotropin

POSEIDON groups 1 and 2 patients respond poorly (<4 oocytes retrieved) or sub-optimally (4–9 oocytes retrieved) to gonadotropin stimulation despite the presence of adequate ovarian parameters, which negatively affect their cumulative chances of delivering a baby using Assisted Reproductive Techno...

Descripción completa

Detalles Bibliográficos
Autores principales:	Conforti, Alessandro, Esteves, Sandro C., Cimadomo, Danilo, Vaiarelli, Alberto, Di Rella, Francesca, Ubaldi, Filippo Maria, Zullo, Fulvio, De Placido, Giuseppe, Alviggi, Carlo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2019
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6610322/ https://www.ncbi.nlm.nih.gov/pubmed/31316461 http://dx.doi.org/10.3389/fendo.2019.00387

Ejemplares similares

Pharmacogenetics of FSH Action in the Female
por: Conforti, Alessandro, et al.
Publicado: (2019)

Improving Reporting of Clinical Studies Using the POSEIDON Criteria: POSORT Guidelines
por: Esteves, Sandro C., et al.
Publicado: (2021)

Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials
por: Conforti, Alessandro, et al.
Publicado: (2021)

Understanding Ovarian Hypo-Response to Exogenous Gonadotropin in Ovarian Stimulation and Its New Proposed Marker—The Follicle-To-Oocyte (FOI) Index
por: Alviggi, Carlo, et al.
Publicado: (2018)

Impact of Maternal Age on Oocyte and Embryo Competence
por: Cimadomo, Danilo, et al.
Publicado: (2018)

Validation of ART Calculator for Predicting the Number of Metaphase II Oocytes Required for Obtaining at Least One Euploid Blastocyst for Transfer in Couples Undergoing in vitro Fertilization/Intracytoplasmic Sperm Injection
por: Esteves, Sandro C., et al.
Publicado: (2020)

The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
por: Conforti, Alessandro, et al.
Publicado: (2019)

Correction to: The role of recombinant LH in women with hypo-response to controlled ovarian stimulation: a systematic review and meta-analysis
por: Conforti, Alessandro, et al.
Publicado: (2019)

DuoStim – a reproducible strategy to obtain more oocytes and competent embryos in a short time-frame aimed at fertility preservation and IVF purposes. A systematic review
por: Vaiarelli, Alberto, et al.
Publicado: (2020)

The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists
por: Esteves, Sandro C., et al.
Publicado: (2019)

Double Stimulation in the Same Ovarian Cycle (DuoStim) to Maximize the Number of Oocytes Retrieved From Poor Prognosis Patients: A Multicenter Experience and SWOT Analysis
por: Vaiarelli, Alberto, et al.
Publicado: (2018)

Advanced Maternal Age in IVF: Still a Challenge? The Present and the Future of Its Treatment
por: Ubaldi, Filippo Maria, et al.
Publicado: (2019)

Luteal phase anovulatory follicles result in the production of competent oocytes: intra-patient paired case-control study comparing follicular versus luteal phase stimulations in the same ovarian cycle
por: Cimadomo, Danilo, et al.
Publicado: (2018)

Effect of Genetic Variants of Gonadotropins and Their Receptors on Ovarian Stimulation Outcomes: A Delphi Consensus
por: Conforti, Alessandro, et al.
Publicado: (2022)

Clinical and laboratory key performance indicators in IVF: A consensus between the Italian Society of Fertility and Sterility and Reproductive Medicine (SIFES-MR) and the Italian Society of Embryology, Reproduction and Research (SIERR)
por: Vaiarelli, Alberto, et al.
Publicado: (2023)

The Impact of Unbalanced Maternal Nutritional Intakes on Oocyte Mitochondrial Activity: Implications for Reproductive Function
por: Fabozzi, Gemma, et al.
Publicado: (2021)

Defining Low Prognosis Patients Undergoing Assisted Reproductive Technology: POSEIDON Criteria—The Why
por: Esteves, Sandro C., et al.
Publicado: (2018)

The Distribution of Stroma and Antral Follicles Differs between Insulin-Resistance and Hyperandrogenism-Related Polycystic Ovarian Syndrome
por: Alviggi, Carlo, et al.
Publicado: (2017)

Pre-implantation genetic testing in ART: who will benefit and what is the evidence?
por: Vaiarelli, Alberto, et al.
Publicado: (2016)

Severe male factor in in vitro fertilization: definition, prevalence, and treatment. An update
por: Mazzilli, Rossella, et al.
Publicado: (2021)

Personalized Nutrition in the Management of Female Infertility: New Insights on Chronic Low-Grade Inflammation
por: Fabozzi, Gemma, et al.
Publicado: (2022)

Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2017)

Response: Commentary: Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the “Personalized” Medicine Era: A Meta-analysis
por: Santi, Daniele, et al.
Publicado: (2018)

COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine
por: Vaiarelli, Alberto, et al.
Publicado: (2020)

Reduction of multiple pregnancies in the advanced maternal age population after implementation of an elective single embryo transfer policy coupled with enhanced embryo selection: pre- and post-intervention study
por: Ubaldi, Filippo Maria, et al.
Publicado: (2015)

Innovative Strategies for Fertility Preservation in Female Cancer Survivors: New Hope from Artificial Ovary Construction and Stem Cell-Derived Neo-Folliculogenesis
por: Canosa, Stefano, et al.
Publicado: (2023)

Bisphenol A-Induced Epigenetic Changes and Its Effects on the Male Reproductive System
por: Cariati, Federica, et al.
Publicado: (2020)

Management Strategies for POSEIDON Groups 3 and 4
por: Haahr, Thor, et al.
Publicado: (2019)

Male factor infertility and assisted reproductive technologies: indications, minimum access criteria and outcomes
por: Mazzilli, R., et al.
Publicado: (2023)

Future Perspectives of POSEIDON Stratification for Clinical Practice and Research
por: Humaidan, Peter, et al.
Publicado: (2019)

Editorial: POSEIDON’s Stratification of ‘Low Prognosis’ Patients in ART: The WHY, the WHAT, and the HOW
por: Esteves, Sandro C., et al.
Publicado: (2021)

Management of Poor Responders in IVF: Is There Anything New?
por: Ubaldi, Filippo, et al.
Publicado: (2014)

Original delayed-start ovarian stimulation protocol with a gonadotropin-releasing hormone antagonist, medroxyprogesterone acetate, and high-dose gonadotropin for poor responders and patients with poor-quality embryos
por: Takeuchi, Kazuhiro, et al.
Publicado: (2023)

Analysis of relative factors and prediction model for optimal ovarian response with gonadotropin-releasing hormone antagonist protocol
por: Jiang, Wenwen, et al.
Publicado: (2022)

Gonadotropins in Keratoconus: The Unexpected Suspects
por: Karamichos, Dimitrios, et al.
Publicado: (2019)

Modulation of Gonadotropins Activity by Antibodies
por: Kara, Elodie, et al.
Publicado: (2019)

Allosteric modulation of gonadotropin receptors
por: Lazzaretti, Clara, et al.
Publicado: (2023)

Live Birth in Woman With Premature Ovarian Insufficiency Receiving Ovarian Administration of Platelet-Rich Plasma (PRP) in Combination With Gonadotropin: A Case Report
por: Hsu, Chao-Chin, et al.
Publicado: (2020)

Functional Ovarian Cysts in Artificial Frozen-Thawed Embryo Transfer Cycles With Depot Gonadotropin-Releasing Hormone Agonist
por: Ji, Hui, et al.
Publicado: (2022)

Gonadotropins at Advanced Age - Perhaps They Are Not So Bad? Correlations Between Gonadotropins and Sarcopenia Indicators in Older Adults
por: Guligowska, Agnieszka, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_v0nf34gvb65npasq4nglnk6euv